CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹2,563 Cr | ₹1,507 Cr | ₹1,031 Cr | ₹975 Cr | ₹1,151 Cr |
What is the latest Short Term Loans and Advances ratio of CIPLA ?
Year | Short Term Loans and Advances |
---|---|
Mar2023 | ₹2,563 Cr |
Mar2022 | ₹1,507 Cr |
Mar2021 | ₹1,031 Cr |
Mar2020 | ₹975 Cr |
Mar2019 | ₹1,151 Cr |
How is Short Term Loans and Advances of CIPLA Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2023 | ₹2,563 Cr | 70.07 | |
Mar2022 | ₹1,507 Cr | 46.18 | |
Mar2021 | ₹1,031 Cr | 5.77 | |
Mar2020 | ₹975 Cr | -15.30 | |
Mar2019 | ₹1,151 Cr | - |
Compare Short Term Loans and Advances of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹115,034.3 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics | |
MANKIND PHARMA | ₹92,708.2 Cr | -2.3% | 0.1% | NA | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 1.1% |
-4.8% |
56.4% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses